AXIS CLINICALS LIMITED

AXIS CLINICALS LIMITED is a service provider, specifically a Contract Research Organization (CRO). it's neither a factory nor a trader. And Generally speaking AXIS CLINICALS LIMITED

Company Overview:

AXIS CLINICALS LIMITED is a prominent Contract Research Organization (CRO) based in India. From what I've seen, The company is dedicated to providing high-condition and thorough clinical research services to the global medical, biopharmaceutical, and generic industries. And It plays a vital role in supporting drug research by conducting essential studies required to regulatory approvals worldwide. Business Model:

AXIS CLINICALS LIMITED operates purely as a service provider. Its business model focuses on delivering specialized scientific and technical expertise rather than manufacturing or trading physical items. Crazy, isn't it?. The company performs various clinical and analytical studies on a contractual basis to its clients. Key Services Offered:

Bioequivalence and Bioavailability Studies: Conducting comparative studies to generic drug items to demonstrate therapeutic equivalence. Clinical Trials: Managing and executing Phase I to Phase IV clinical trials across various therapeutic areas. But Pharmacokinetic and Pharmacodynamic Studies: Analyzing the behavior of drugs in the body, including absorption, distribution, physiological processes, and excretion. Moreover Bioanalytical Services: Developing and validating analytical methods and performing sample analysis to drug and metabolite quantification. Data regulation and Biostatistics: Providing robust data regulation solutions and expert statistical analysis to clinical study data. Regulatory Affairs Support: Assisting clients with regulatory submissions and ensuring compliance with international guidelines. But Furthermore Facilities and Standards:

The company typically operates cutting-edge clinical pharmacology units and state-of-the-art bioanalytical laboratories. But It adheres strictly to international regulatory guidelines such as Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and Good Documentation Practice (GDP). AXIS CLINICALS LIMITED often undergoes regular inspections and approvals from leading global regulatory authorities including the US FDA, MHRA (UK), ANVISA (Brazil), WHO, and the DCGI (India), ensuring the highest condition and integrity of its research. Mission:

To accelerate the drug research process to its global partners by providing ethical, efficient, and responsibly sound clinical research solutions.

Based on available information, AXIS CLINICALS LIMITED (India) primarily focuses on:

* In-vitro diagnostic reagents

* Rapid diagnostic kits

* Clinical chemistry analyzers

* Hematology analyzers

* ELISA kits

* Molecular diagnostics products

* Point-of-care testing devices